["{\"step_by_step_thinking\": \"The patient has been diagnosed with type 2 diabetes 3 months ago and has been started on metformin and lifestyle modifications. His HbA1C is 8.5% and serum glucose is 240 mg/dL, indicating that the current treatment is not fully effective in controlling his blood sugar levels. The patient also complains of occasional numbness in both hands and feet, which may be related to diabetic neuropathy.\n\nThe goal is to improve glycemic control and prevent complications. Since metformin monotherapy is already being used, it's unlikely that adding another medication from the same class (thiazolidinedione) would be effective. Sulfonylureas are typically used in combination with other agents, so starting a sulfonylurea as a single agent may not be the best choice.\n\nThis leaves us with two options: adding insulin or continuing metformin monotherapy. Given the patient's suboptimal glycemic control and presence of neuropathy, it seems that insulin therapy may be more effective in improving his condition. Therefore, starting basal-bolus insulin appears to be the most appropriate next step.\", \"answer_choice\": \"A\"}"]